VELINDRE NHS TRUST. Trust Procedure PROCEDURE FOR THE IMPLEMENTATION OF NATIONAL INSTITUTE OF HEALTH & CLINICAL EXCELLENCE (NICE) GUIDANCE
|
|
- Simon Charles
- 5 years ago
- Views:
Transcription
1 Clinical Excellence (NICE) Guidance VELINDRE NHS TRUST Trust Procedure Black 21 PROCEDURE FOR THE IMPLEMENTATION OF NATIONAL INSTITUTE OF HEALTH & CLINICAL EXCELLENCE (NICE) GUIDANCE Lead: Lisa Heydon-Mann Quality & Safety Manager Ref: Black 21 Page 1 of 14
2 Clinical Excellence (NICE) Guidance EXECUTIVE SUMMARY Overview: Trust Procedure for the Dissemination of NICE Guidance This Procedure ensures the Trust has a robust system for recording receipt, distribution and implementation of National Institute of Health & Clinical Excellence (NICE) Guidance. Who is the policy intended for: Key Messages included within the policy: Velindre NHS Trust and hosted organisations NICE guidance is developed using the expertise of the NHS and the wider healthcare community including NHS staff, healthcare professionals, patients and carers, industry and the academic world. NICE produces guidance on public health, health technologies and clinical practice. For the purposes of this Procedure Guidance incorporates: Technology Appraisals. Clinical Guidelines Interventional Procedures Public Health Intervention Guidance All Wales Medicines Strategy Group As part of this procedure it is also necessary to ensure that there is a process in place for assessing any associated costs of the Guidance. Implementation plans will need to be developed by the Service Divisions. PLEASE NOTE THIS IS ONLY A SUMMARY OF THE PROCEDURE AND SHOULD BE READ IN CONJUNCTION WITH THE FULL DOCUMENT. Ref: Black 21 Page 2 of 14
3 Clinical Excellence (NICE) Guidance Contents 1. Introduction Page 3 2. Background Page 3 3. Scope Page 5 4. Duties Page 5 5. Dissemination Page 7 6. Appendices Page 9 Appendix 1 - NICE Guidance Dissemination Flow Chart Appendix 2 - Circulation of NICE Guidance Form Medical Director Appendix 3 - Circulation of NICE Guidance Form Divisional Director Page 10 Page 11 Page 12 Appendix 4 Implementation of NICE Guidance Page 13 Ref: Black 21 Page 3 of 14
4 1. Introduction The National Institute for Health and Clinical Excellence (NICE) was originally established in April 1999 to promote clinical excellence and the effective use of resources in the health service in England and Wales. Following the Arms Length Bodies Review undertaken by the Department of Health in 2004, NICE merged with the former English Health Development Agency to become the National Institute for Health and Clinical Excellence (also to be known as NICE), and was re-established on 1 April 2005 as an England only Special Health Authority. The Welsh Government has an agreement in place with NICE covering the Institute's technology appraisals, clinical guidelines and interventional procedure guidance, which all continue to apply in Wales. Guidance being developed, and published by NICE can be found by accessing NICE work programme The All Wales Medicines Strategy Group (AWMSG) was formed using powers in section 2 of and Schedule 14 to the National Health Service (Wales) Act The aim of the Strategy group is to provide advice in an effective, efficient and transparent manner to the Assembly on strategic medicines management and prescribing. 2. Background NICE procedures guidance in three areas of health: Public Health guidance on the promotion of good health and the prevention of ill health for those working in the NHS, local authorities and the wider public and voluntary sector. Health Technologies guidance on the use of new and existing medicines, treatments and procedures within the NHS. Clinical Practice guidance on the appropriate treatment and care of people with specific diseases and conditions within the NHS. Doing Well, Doing Better: Standards for Health Services in Wales, the health standards for Wales, set out the Welsh Government's common framework of standards to support the NHS and partner organisations in providing effective, timely and quality services across all healthcare settings. Ref: Black 21 Page 4 of 14
5 Standard 7 requires organisations and services to ensure that patients and service users are provided with safe, effective treatment and care that is based on agreed best practice and guidelines, including those defined in NICE guidance. For the purposes of this Procedure Guidance incorporate: 2.1 Definitions Technology Appraisals Clinical Guidelines Interventional Procedures Public Health Intervention Guidance All Wales Medicines Strategy Group Guidance Technology Appraisal Guidance Technology Appraisal guidance issued by NICE is subject to a funding direction issued by the Welsh Government s Minister for Health and Social Services. This places a statutory obligation on Local Health Boards and NHS Trusts in Wales to make available health technologies recommended by NICE within three months of the date of publication, unless otherwise instructed by the Welsh Government. Clinical Guidelines Although clinical guidelines issued by the Institute are not subject to the Assembly's three months funding Direction, the Welsh Government expects NHS bodies in Wales to take full account of the recommendations made by the Institute when commissioning and delivering services Clinical Guidelines and Public Health Guidelines should be implemented within Trust s current resources as no additional funding is made available. No specific timescale for implementation is set, since they often involve changes that may take a number of years to implement. Once NICE publishes clinical guidance, health professionals and the organisations that employ them are expected to take it fully into account when deciding what treatments to give people. However, NICE guidance does not replace the knowledge and skills of individual health professionals who treat service users; it is still up to them to make decisions about a particular service in consultation with the service user and/or their guardian or carer as appropriate. Interventional Procedures These contain recommendations about whether interventional procedures used for diagnosis or treatment are safe enough and work well enough for routine use. Ref: Black 21 Page 5 of 14
6 NICE defines interventional procedures as: Making a cut or hole to gain access to the inside of a patient s body for example, when carrying out an operation or inserting a tube into a blood vessel. Gaining access to a body cavity (such as the digestive system. Lungs, womb or bladder) without cutting into the body for example examining or carrying out treatment on the inside of the stomach using an instrument inserted via the mouth. Using electromagnetic radiation (which includes X-rays, lasers, gamma rays and ultraviolet light) for example, using a laser to treat eye problems. Public Health Guidance Public Health Guidance deals with broader activities for promoting good health and preventing ill health. This guidance may focus on a topic, particular population or a particular setting. All Wales Medicines Strategy Group Guidance As part of their remit, the Group is responsible for developing timely, independent and authoritative advice on new drugs and on the cost implications of making these drugs routinely available on the NHS. (This would include making interim recommendations on the place in treatment of drugs awaiting appraisal by the National Institute for Clinical Excellence (NICE). 3. Scope This policy details the responsibility of staff within Velindre NHS Trust and a hosted organisation confers responsibilities on individual clinicians and managers. 4. Duties Trust Board (and delegated responsibility to Quality & Safety Committee) The Board has accountability for ensuring Trust compliance with NICE guidance; including considering and approving any decision NOT to implement NICE guidance. The Quality & Safety Committee has delegated responsibility for providing assurance to the Board via the Trust Executive Leads on the Trusts arrangements for effectively managing NICE compliance. Director of Nursing and Medical Director The Director of Nursing and Medical Director are the Executive Leads for the management of NICE Guidance. The Medical Director is also responsible for assessing applicability of the guidance. Ref: Black 21 Page 6 of 14
7 Quality & Safety Manager The Trust Quality & Safety Manager through the Quality & Safety department will facilitate the process for monitoring the implementation of NICE guidance including the disseminating new guidance, tracking baseline assessments, reporting compliance by:- Disseminating guidance across the Trust. Preparing quarterly assurance reports for the Quality & Safety Committee. Maintaining and updating a database of applicable NICE guidance. Linking with the Divisional Coordinators/Leads. Quality & Safety Committee The Quality & Safety Committee has the responsibility to ensure the NICE Implementation Procedure is fully implemented through: Receiving and reviewing summary information and key performance indicators reports on a quarterly basis. Monitoring the Trust compliance with NICE guidance and risk status. Ensuring the overall effectiveness of the process for managing NICE guidance are robust and effective. Service Directors (Trust and Hosted organisations) The Service Director will ensure the implementation of a robust process for NICE guidance. This includes notifying the Trust Quality & Safety Committee of any implementation risks identified as part of the quarterly reporting mechanism to the Trust Quality & Safety Committee. A lead clinician will be identified to support the Service Director in performing this function. The Service Division will Evaluate the current situation against the Guidance Consider completed baseline assessments for their area of responsibility. Ensure an impact assessment is completed identifying any risks involved in implementing/ not implementing the guidance. Impact assessments should be undertaken with the appropriate staff and consider all areas of the workplace and activities likely to be affected by the guidance. (Refer to Velindre Policy on Prescribing Unlicensed Medicines for a suggested toolkit). Ensure that the Finance Department is aware of the Guidance and is involved in assessing costs, if any, associated with the Guidance and any other financial implications there will be. Additionally, to confirm any costs already identified as part of the forward planning process Hold responsibility for developing business cases if a resources implication is identified and escalating to the Quality &Safety Committee if appropriate. Develop an action plan required to achieve the standard set out in the Guidance. Ref: Black 21 Page 7 of 14
8 Retains overall responsibilities for compliance with NICE guidance for their service area Consult appropriately with all key stakeholders and partner organisations. Director of Finance Ensure resource implications of NICE implementation are factored into the Trusts annual business planning procedures and taken into account in negotiations. Head of Pharmacy Participate in NICE assessments, during business planning and implementation stages and also has a responsibility for notifying Drugs & Therapeutics Committee of required formulary additions. All Clinicians Individual Clinicians are responsible for ensuring that they: Are aware of guidance which is relevant to their area of work Read and comply with disseminated NICE Guidance including supporting the review, implementation and monitoring phases of the policy. Address any training needs identified with the education and Workforce Development department. Raise any queries about implementation with the lead clinician and/or nominated Guidance lead. Once NICE guidance is published, health professional are expected to take it fully into account when exercising their clinical judgement. However, NICE guidance neither does nor overrides the individual responsibility of health professionals to make appropriate decisions according to the circumstances of the individual patient in consultation with the patient and/or their guardian/carer. ( 5. Process for Disseminating and Implementing NICE Guidance Receipt of Guidance Guidance is received from NICE/AWMSG via the Chief Executive and circulated to the Quality & Safety Manager. The Guidance is then disseminated by Quality & Safety department to the Medical Director who will assess its relevance to the Trust (see Appendix 1 flow chart of dissemination). The Medical Director will complete the form at Appendix 2 and return it to the Q&S department for action and filing within 5 working days of receipt. The Q&S department will disseminate the Guidance to the relevant Divisional Director for action. The Divisional Director will complete part 1 and 2 of the form at Ref: Black 21 Page 8 of 14
9 Appendix 3 and forward it to the identified Site Specific/Service Lead within the organisation. Assessment The Lead Clinician and Service Directors are responsible for ensuring that the service reviews its compliance with NICE guidance and submits a statement (Appendix 3) reflecting the initial understanding of local compliance to the Quality &Safety Department within 8 weeks of receipt of guidance. The Drugs and Therapeutic Committee will support the implementation of NICE Technology Appraisals for medicines and NICE guidelines where medicines are a significant feature. Implementation The service will then undertake a gap analysis of the recommendations against current practice and complete an action plan which should be submitted to the relevant Service groups within 3 months of receipt of guidance. Where the service is not compliant with NICE guidance the service should assess the risk using the Trust standard scoring risk matrix and consider it for inclusion in departmental and/or service risk registers. The action plan should include as a minimum: Actions required to implement the recommendations Any additional resources required for all affected departments Names of people responsible for implementing the action plan. Date by which the action plan will be implemented. Any barriers to implementation that cannot be resolved by the speciality. The nominated speciality lead will send a copy of the completed action plan to an identified local Coordinator. Gap Analysis Service Divisions will have a robust process in place to consider baseline assessments and recommendations either not to implement or action required to ensure compliance with the guidance. The Service Division will produce an action plan of work that is required to fully meet the requirements of the guidance issued. Where resource implications are identified, or decisions not to implement are made, the Service Director will be responsible for escalating issues of guidance to the Quality & Safety Committee for consideration and approval. Monitoring Reports will be provided on a quarterly basis to the Quality & Safety Committee providing assurance of compliance to the guidance. Ref: Black 21 Page 9 of 14
10 The Service Division will monitor local implementation, compliance and effectiveness of the process to manage NICE guidance. 6. Appendices Appendix 1 NICE Guidance Dissemination Flow Chart Appendix 2 Circulation of NICE Guidance Form Medical Director Appendix 3 Circulation of NICE Guidance Form Divisional Director Appendix 4 Implementation of NICE Guidance Ref: Black 21 Page 10 of 14
11 Appendix 1 NICE Guidance Dissemination Flow Chart NICE Guidance Chief Executive Quality & Safety Department Medical Director Quality & Safety Department Director Velindre Cancer Services Director Hosted Organisation Director Welsh Blood Service Divisional Lead/Clinical Site Specialist Divisional Lead Ref: Black 21 Page 11 of 14
12 Appendix 2 Circulation of NICE Guidance Form Medical Director Title of Nice Guidance/Guidelines/ Appraisals/ Interventions/AWMS Guidance: Date Received: Medical Director to complete this section and return within 5 working days Trust Implications: Yes No Please provide reasons for your assessment: Divisional Director Responsible: Medical Director Signature: Date: Form to be returned to: Quality & Safety Department Chief Executive Offices Trust Headquarters 2 Charnwood Court Parc Nantgarw Cardiff CF15 7QZ Ref: Black 21 Page 12 of 14
13 Appendix Three Circulation of NICE Guidance Form Divisional Director Title of Guidance: Date Received: Director to complete this section and forward to Service Lead Responsibility for co-ordinating and reporting on implementation (name): Director Signature & Date: Site Specific/Service Lead to complete this section and forward to Divisional Director (and Clinical Change Facilitator for VCC cases) Please provide overview of implementation: Date of Discussion: Relevant Group/Staff: Outcome of discussion: Resource implication identified and notified: Proposed audit details: (continue overleaf) Form to be returned to: (1) Divisional Director (2) Clinical Audit Facilitator (VCC only) (3) Clinical Change Facilitator (VCC only) Ref: Black 21 Page 13 of 14
14 Implementation of NICE Guidance Appendix 4 Title of Guidance: Date Received: Responsibility for co-ordinating and reporting on implementation (name): Division: Please provide overview of implementation: Audit details: Ref: Black 21 Page 14 of 14
The Newcastle upon Tyne Hospitals NHS Foundation Trust. Introduction and Development of New Clinical Interventional Procedures
The Newcastle upon Tyne Hospitals NHS Foundation Trust Introduction and Development of New Clinical Interventional Procedures Version No.: 2.1 Effective From: 27 November 2017 Expiry Date: 7 January 2019
More informationRESPONSE TO RECOMMENDATIONS FROM THE HEALTH & SOCIAL CARE COMMITTEE: INQUIRY INTO ACCESS TO MEDICAL TECHNOLOGIES IN WALES
Recommendations 1, 2, 3 1. That the Minister for Health and Social Services should, as a matter of priority, identify means by which a more strategic, coordinated and streamlined approach to medical technology
More informationAppendix 1. Policy on the Dissemination, Implementation and Monitoring of National Clinical Guidance
Appendix 1 Policy on the Dissemination, Implementation and Monitoring of National Clinical Guidance Policy Title: Executive Summary: Policy on the dissemination, implementation and monitoring of national
More informationNHS QIS & NICE Advice. defi nitions & status
NHS QIS & NICE Advice defi nitions & status NHS Quality Improvement Scotland 2006 First published August 2006 You can copy or reproduce the information in this document for use within NHSScotland and for
More informationVELINDRE NHS TRUST. Welsh Language Policy
VELINDRE NHS TRUST Ref: Black 14 TRUST POLICY Welsh Language Policy, Welsh Language Officer Ref: BLACK 14 Page 1 of 17 This is Velindre Trusts third Welsh Language Policy and has been developed under the
More informationNew Clinical Procedures, Interventions, Techniques or Expanded Practice Policy, Introduction of
New Clinical Procedures, Interventions, Techniques or Expanded Practice Policy, Introduction of Document Author Written By: Clinical Director for Surgery, Women and Children s CBU Authorised Authorised
More informationThis controlled document shall not be copied in part or whole without the express permission of the author or the author s representative.
This document is also available in large print and other formats and languages, upon request. Please call NHS Grampian Corporate Communications on (01224) 551116 or (01224) 552245. This controlled document
More informationCentral Alerting System (CAS) Policy
Document Title Reference Number Lead Officer Author(s) (name and designation) Ratified By Central Alerting System (CAS) Policy NTW(O)17 Gary O Hare Executive Director of Nursing and Operations Tony Gray
More informationPOLICY ON THE IMPLEMENTATION OF NICE GUID ANCE
POLICY ON THE IMPLEMENTATION OF NICE GUID ANCE Document Type Corporate Policy Unique Identifier CO-019 Document Purpose To outline the process for the implementation and compliance with NICE guidance and
More informationNICE Charter Who we are and what we do
NICE Charter 2017 Who we are and what we do 1. The National Institute for Health and Care Excellence (NICE) is the independent organisation responsible for providing evidence-based guidance on health and
More informationClinical Audit Strategy
Clinical Audit Strategy Clinical Audit Strategy 2012/15 Document Type Strategy Unique Identifier CL-016 Document Purpose To map out the strategic direction of Clinical Audit within the Trust for the next
More informationWELSH RENAL CLINICAL NETWORK TERMS OF REFERENCE
INTRODUCTION WELSH RENAL CLINICAL NETWORK TERMS OF REFERENCE In accordance with WHSSC Standing Order 3, the Joint Committee may and, where directed by the LHBs jointly or the Welsh Government must, appoint
More informationNon Medical Prescribing Policy
Non Medical Prescribing Policy Author: Sponsor/Executive: Responsible committee: Ratified by: Consultation & Approval: (Committee/Groups which signed off the policy, including date) This document replaces:
More informationCLINICAL AND CARE GOVERNANCE STRATEGY
CLINICAL AND CARE GOVERNANCE STRATEGY Clinical and Care Governance is the corporate responsibility for the quality of care Date: April 2016 2020 Next Formal Review: April 2020 Draft version: April 2016
More informationThe Newcastle upon Tyne Hospitals NHS Foundation Trust. Implementation Policy for NICE Guidelines
The Newcastle upon Tyne Hospitals NHS Foundation Trust Implementation Policy for NICE Guidelines Version No.: 5.3 Effective From: 08 May 2017 Expiry Date: 02 March 2019 Date Ratified: 23 February 2017
More informationDocument Details Clinical Audit Policy
Title Document Details Clinical Audit Policy Trust Ref No 1538-31104 Main points this document covers This policy details the responsibilities and processes associated with the Clinical Audit process within
More informationBurton Hospitals NHS Foundation Trust. On: 30 January Review Date: November Corporate / Directorate. Department Responsible for Review:
POLICY DOCUMENT Burton Hospitals NHS Foundation Trust MANAGEMENT OF EXTERNAL AGENCY VISITS, INSPECTIONS, ACCREDITATION AND RESULTING RECOMMENDATIONS Approved by: Trust Executive Committee On: 30 January
More informationQuality and Governance Committee. Terms of Reference
Quality and Governance Committee Terms of Reference 1. Constitution 1.1 The Clinical Commissioning Group s Governing Body hereby resolves to establish a Committee of the Governing Body known as the Quality
More informationPROGRESS WITH NPSA ALERT IMPLEMENTATION
AGENDA ITEM 3.5 4 th September 2013 PROGRESS WITH NPSA ALERT IMPLEMENTATION Executive : Executive Director of Nursing Author: Assistant Director of Patient Safety & Quality Contact Details for further
More informationIndependent Mental Health Advocacy. Guidance for Commissioners
Independent Mental Health Advocacy Guidance for Commissioners DH INFORMATION READER BOX Policy HR / Workforce Management Planning / Performance Clinical Estates Commissioning IM&T Finance Social Care /
More informationTitle: Replacement of the Commissioning Advisory Forum Agenda Item: 9
Meeting of Bristol Clinical Commissioning Group To be held on Tuesday, 2 July 2013 commencing at 1.30 pm in the BAWA Centre Title: Replacement of the Commissioning Advisory Forum Agenda Item: 9 1 Purpose
More informationMental Health (Wales) Measure Implementing the Mental Health (Wales) Measure Guidance for Local Health Boards and Local Authorities
Mental Health (Wales) Measure 2010 Implementing the Mental Health (Wales) Measure 2010 Guidance for Local Health Boards and Local Authorities Januar y 2011 Crown copyright 2011 WAG 10-11316 F6651011 Implementing
More informationQUALITY COMMITTEE. Terms of Reference
QUALITY COMMITTEE Terms of Reference CONSTITUTION 1. The Board of Directors approved the establishment of the Quality Committee (known as the Committee in these terms of reference) for the purpose of:
More informationFramework for managing performer concerns NHS (Performers Lists) (England) Regulations 2013
Framework for managing performer concerns NHS (Performers Lists) (England) Regulations 2013 Information reader box NHS England INFORMATION READER BOX Directorate Medical Operations Patients and Information
More informationLearning from Deaths Policy A Framework for Identifying, Reporting, Investigating and Learning from Deaths in Care.
Learning from Deaths Policy A Framework for Identifying, Reporting, Investigating and Learning from Deaths in Care. Associated Policies Being Open and Duty of Candour policy CG10 Clinical incident / near-miss
More informationIssue date: October Guide to the multiple technology appraisal process
Issue date: October 2009 Guide to the multiple technology appraisal process Guide to the multiple technology appraisal process Issued: October 2009 This document is one of a series describing the processes
More informationNHS. The guideline development process: an overview for stakeholders, the public and the NHS. National Institute for Health and Clinical Excellence
NHS National Institute for Health and Clinical Excellence Issue date: April 2007 The guideline development process: an overview for stakeholders, the public and the NHS Third edition The guideline development
More informationStatement of responsibilities for grants certification Wales Audit Office
Statement of responsibilities for grants certification Wales Audit Office Date issued: December 2016 Document reference: 707A2016 This document has been prepared as part of work performed in accordance
More informationSPONSORSHIP AND JOINT WORKING WITH THE PHARMACEUTICAL INDUSTRY
SPONSORSHIP AND JOINT WORKING WITH THE PHARMACEUTICAL INDUSTRY 1 SUMMARY This document sets out Haringey Clinical Commissioning Group policy and advice to employees on sponsorship and joint working with
More informationJOB DESCRIPTION DIRECTOR OF SCREENING. Author: Dr Quentin Sandifer, Executive Director of Public Health Services and Medical Director
JOB DESCRIPTION DIRECTOR OF SCREENING Author: Dr Quentin Sandifer, Executive Director of Public Health Services and Medical Director Date: 1 November 2017 Version: 0d Purpose and Summary of Document: This
More informationPutting Things Right Policy. Procedure for the Management Of Public Service Ombudsman for Wales Investigations
Aneurin Bevan Health Board Putting Things Right Policy Procedure for the Management Of Public Service Ombudsman for Wales Investigations N.B. Staff should be discouraged from printing this document. This
More informationNHS England (Wessex) Clinical Senate and Strategic Networks. Accountability and Governance Arrangements
NHS England (Wessex) Clinical Senate and Strategic Networks Accountability and Governance Arrangements Version 6.0 Document Location: This document is only valid on the day it was printed. Location/Path
More informationGuidance on NHS Wales Patient Safety Solutions. December 2014
Guidance on NHS Wales Solutions December 2014 Digital ISBN 978-1-4734-2546-0 Crown copyright 2014 WG23419 Contents Background 1 Compliance 2 Appendix 1 Template and explanatory notes for a Alert 3 Appendix
More informationNATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE. Interim Process and Methods of the Highly Specialised Technologies Programme
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE Principles Interim Process and Methods of the Highly Specialised Technologies Programme 1. Our guidance production processes are based on key principles,
More informationPATIENT ACCESS POLICY (ELECTIVE CARE) UHB 033 Version No: 1 Previous Trust / LHB Ref No: Senior Manager, Performance and Compliance.
Reference No: PATIENT ACCESS POLICY (ELECTIVE CARE) UHB 033 Version No: 1 Previous Trust / LHB Ref No: Trust 364 Documents to read alongside this Policy. Ministerial Letter EH/ML/004/09 WAG Rules for Managing
More informationProvision of Adult Thoracic Surgery in South Wales Mid-Point Review
Provision of Adult Thoracic Surgery in South Wales Mid-Point Review Status For Review Version Number 1.0 Publication Date 27th July 2018 V1.0 27 rd July 2018 2018 Contents 1. Introduction... 3 2. Context...
More informationINTEGRATION SCHEME (BODY CORPORATE) BETWEEN WEST DUNBARTONSHIRE COUNCIL AND GREATER GLASGOW HEALTH BOARD
INTEGRATION SCHEME (BODY CORPORATE) BETWEEN WEST DUNBARTONSHIRE COUNCIL AND GREATER GLASGOW HEALTH BOARD This integration scheme is to be used in conjunction with the Public Bodies (Joint Working) (Integration
More informationImplementation of Quality Framework Update
Joint Committee Meeting 26 January 2016 Title of the Committee Paper Framework Update Executive Lead: Director of Nursing & Quality Assurance Author: Director of Nursing & Quality Assurance Contact Details
More informationPHARMACEUTICAL REPRESENTATIVE POLICY NOVEMBER This policy supersedes all previous policies for Medical Representatives
PHARMACEUTICAL REPRESENTATIVE POLICY VEMBER 2017 This policy supersedes all previous policies for Medical Representatives Policy title Pharmaceutical Representative Policy Policy PHA39 reference Policy
More informationJOB DESCRIPTION JOB DESCRIPTION
JOB DESCRIPTION JOB DESCRIPTION Medical Director GOSH Profile Great Ormond Street Hospital for Children NHS Foundation Trust (GOSH) is a national centre of excellence in the provision of specialist children's
More informationEquality and Health Inequalities Strategy
Equality and Health Inequalities Strategy 1 Schematic of the Equality and Health Inequality Strategy Improving Lives: People and Patients Listening and Learning Gaining Knowledge Making the System Work
More informationCOMPLAINTS ANNUAL REPORT
COMPLAINTS ANNUAL REPORT 2006-2007. CONTENTS 1. Introduction to Velindre NHS Trust... 3 1.1 Velindre Cancer Centre... 3 1.2 Public Health Division... 3 1.3 Welsh Blood Service... 5 1.4 Welsh Cancer Intelligence
More informationLEARNING FROM DEATHS POLICY
Issue number: 1st Edition LEARNING FROM DEATHS POLICY Author with contact details Dr Neil Mercer, Associate Medical Director for Clinical Governance Neil.mercer@aintree.nhs.uk tel. 529-5152 Original Issue
More informationBusiness Continuity Plan
Business Continuity Plan Doc Ref: Sitt.149963 1 Contents 1. Executive Summary... 3 2. Objective of the Plan... 7 Definitions... 7 4. Scope of the Plan... 8 5. Stages of Activation of Business Continuity
More informationRegulatory Incident Management Policy
Regulatory Document POLICIES AND PROCEDURES Regulatory Incident Management Policy (16 May 2017) Version control This version (2) of Qualifications Wales Regulatory Incident Management policy was approved
More informationNurse Staffing Approach in Wales
Nurse Staffing Approach in Wales Dr Jean White Chief Nursing Officer Welsh Government / Nurse Director NHS Wales Visiting Professor Cardiff University & University of South Wales Health services in Wales
More informationJob Title: Head of Patient &Public Engagement and Patient Services Directorate: Corporate Affairs Department: Patient and Public Engagement
Job Description Job Title: Head of Patient &Public Engagement and Patient Services Directorate: Corporate Affairs Department: Patient and Public Engagement Grade 8b Tenure: Permanent Location of Post:
More informationUnique Identifier: Review Date: November Issue Status: Approved Version No: 1.4 Issue Date: November 2017
Policy Authors Name & Title: Dr Mark Jackson, Director of Research & Informatics Dr Raphael Perry, Medical Director Scope: Trust Wide Classification: Non Clinical Replaces: version 1.3 To be read in conjunction
More informationHealth, Wellbeing and Social Care Policy Briefing
Health, Wellbeing and Social Care Policy Briefing Introduction The policy field of health, wellbeing and social care has been identified as providing a clear example of the clear red water between policies
More informationNHSLA Risk Management Standards
NHSLA Risk Management Standards 2012-13 for NHS Trusts providing Acute Services Brighton and Sussex University Hospitals NHS Trust Level 1 October 2012 Contents Executive Summary... 3 Assessment Outcome...
More informationCare Home support and medicines optimisation: Community Pharmacy National Enhanced Service
Care Home support and medicines optimisation: Community Pharmacy National Enhanced Service 1 1. Introduction Back in 2006 the National Service Framework for Older People in Wales 1 highlighted the problem
More informationMark Drakeford Minister for Health & Social Services
EXPLANATORY MEMORANDUM TO THE NATIONAL HEALTH SERVICE (PHYSIOTHERAPIST, PODIATRIST OR CHIROPODIST INDEPENDENT PRESCRIBERS) (MISCELLANEOUS AMENDMENTS) (WALES) REGULATIONS 2014. This Explanatory Memorandum
More informationCOMMISSIONING SUPPORT PROGRAMME. Standard operating procedure
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE COMMISSIONING SUPPORT PROGRAMME Standard operating procedure April 2018 1. Introduction The Commissioning Support Programme (CSP) at NICE supports the
More informationASBESTOS MANAGEMENT POLICY
AGENDA ITEM 2.4 ASBESTOS MANAGEMENT POLICY Executive Lead: Director of Capital Planning, Estates and Operational Services Author: Estates Health & Safety and Asbestos Manager Contact Details for further
More informationHow NICE clinical guidelines are developed
Issue date: January 2009 How NICE clinical guidelines are developed: an overview for stakeholders, the public and the NHS Fourth edition : an overview for stakeholders, the public and the NHS Fourth edition
More informationMemorandum of Understanding. between. Healthcare Inspectorate Wales. and. NHS Wales National Collaborative Commissioning Unit
Memorandum of Understanding between Healthcare Inspectorate Wales and NHS Wales National Collaborative Commissioning Unit July 2017 Contents Version control Introduction Principles of cooperation Areas
More informationProcess and methods Published: 30 November 2012 nice.org.uk/process/pmg6
The guidelines manual Process and methods Published: 30 November 2012 nice.org.uk/process/pmg6 NICE 2017. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-ofrights).
More informationINCENTIVE SCHEMES & SERVICE LEVEL AGREEMENTS
MAY 2007 INCENTIVE SCHEMES & SERVICE LEVEL AGREEMENTS Practice Based Commissioning North and South Essex Local Medical Committees CLARIFYING THE RELATIONSHIP BETWEEN PBC GROUPS AND PCTS AIMS The aim of
More informationTrust Policy and Procedure Document Ref. No: PP (17) 283. Central Alerting System (CAS) Policy and Procedure. For use in: For use by: For use for:
Trust Policy and Procedure Document Ref. No: PP (17) 283 Central Alerting System (CAS) Policy and Procedure For use in: For use by: For use for: Document owner: Status: All areas of the Trust including
More informationPGDs are permitted for use only by registered health professionals (see enclosed link for full list
NHS England North - Yorkshire and the Humber Region Protocol for the Development, Authorisation and Use of Patient Group Directions for the National Immunisation Programmes 1. Introduction The preferred
More informationFast Track Pathway Tool for NHS Continuing Healthcare
Fast Track Pathway Tool for NHS Continuing Healthcare DH INFORMATION READER BOX Policy Clinical Estates HR / Workforce Commissioner Development IM & T Management Provider Development Finance Planning /
More informationMental Health Act Approval of Approved Clinicians in Wales
Mental Health Act 1983 Approval of Approved Clinicians in Wales March 2011 Crown copyright 2011 ISBN 978 0 7504 6058 3 WAG 10-11545 F7311011 Approval of Approved Clinicians in Wales Introduction...2 Who
More informationBabylon Healthcare Services
Babylon Healthcare Services Limited Babylon Healthcare Services Ltd. Inspection report 60 Sloane Avenue London SW3 3DD Tel: 0207 1000762 Website: www.babylonhealth.com Date of inspection visit: 4 July
More informationCLINICAL GOVERNANCE AND QUALITY COMMITTEE. Final - Terms of Reference - Final
CLINICAL GOVERNANCE AND QUALITY COMMITTEE Final - Terms of Reference - Final CONSTITUTION 1. The Board of Directors approved the establishment of the Clinical Governance and Quality Committee (known as
More informationDelivering Local Health Care
Delivering Local Health Care Accelerating the pace of change Contents Joint foreword by the Minister for Health and Social Services and the Deputy Minister for Children and Social Services Foreword by
More informationAGENDA ITEM 17b Annex (i)
QUALITY AND PATIENT SAFETY COMMITTEE Minutes of the meeting held on 10 th April 2014 Welsh Health Specialised Services Committee Offices Unit 3a, Van Road Caerphilly Business Park Caerphilly CF83 3ED Present
More informationCentral Alerting System (CAS) Policy
Central Alerting System (CAS) Policy Reference No: P_CIG_03 Version 3 Ratified by: LCHS Trust Board Date ratified: 12 th July 2016 Name of responsible committee / Individual Date issued: July 2016 Review
More informationCLINICAL GOVERNANCE AND QUALITY COMMITTEE Terms of Reference
CLINICAL GOVERNANCE AND QUALITY COMMITTEE Terms of Reference CONSTITUTION 1. The Board of Directors approved the establishment of the Clinical Governance and Quality Committee (known as the Committee in
More informationReview of Terms of Reference of Quality Assurance Committee
Review of Terms of Reference of Quality Assurance Committee Governing Body meeting 3 May 2018 H Author(s) Sponsor Director Purpose of Paper Sue Laing, Corporate Services Risk and Governance Manager Mandy
More informationAll areas of the Trust All Trust staff All Patients Deputy Chief Nurse & Chief Pharmacist Final
Trust Policy and Procedure Document Ref. No: PP(15)233 Non-Medical Prescribing Policy For use in: For use by: For use for: Document owner: Status: All areas of the Trust All Trust staff All Patients Deputy
More informationCARE PROGRAMME APPROACH POLICY. Care Programme Approach. Quality and Safety Committee. Disclaimer
CARE PROGRAMME APPROACH POLICY Reference No: UHB 118 Version No: 1 Previous Trust / LHB Ref No: T/226 Documents to read alongside this Policy Care Programme Approach Procedures Classification of document:
More informationDIAGNOSTIC CLINICAL TESTS AND SCREENING PROCEDURES MANAGEMENT POLICY
DIAGNOSTIC CLINICAL TESTS AND SCREENING PROCEDURES MANAGEMENT POLICY (To be read in conjunction with Diagnostic Imaging Requesting and Interpreting Radiographs by Non Medical Practitioners Policy, Consent
More informationOccupational Health & Safety Policy
Occupational Health & Safety Policy N.B. Staff should be discouraged from printing this document. This is to avoid the risk of out of date printed versions of the document. The Intranet should be referred
More informationPublic health guideline Published: 11 November 2011 nice.org.uk/guidance/ph36
Healthcare-associated infections: prevention ention and control Public health guideline Published: 11 November 2011 nice.org.uk/guidance/ph36 NICE 2017. All rights reserved. Subject to Notice of rights
More informationADVISORY COMMITTEE ON CLINICAL EXCELLENCE AWARDS NHS CONSULTANTS CLINICAL EXCELLENCE AWARDS SCHEME (WALES) 2008 AWARDS ROUND
ADVISORY COMMITTEE ON CLINICAL EXCELLENCE AWARDS NHS CONSULTANTS CLINICAL EXCELLENCE AWARDS SCHEME (WALES) 2008 AWARDS ROUND Guide for applicants employed by NHS organisations in Wales This guide is available
More informationAgenda item 3.3 Appendix 4 MANDATORY TRAINING POLICY
Agenda item 3.3 Appendix 4 MANDATORY TRAINING POLICY Reference No: Issued by Policy Manager Version No: 1 Previous Trust / LHB Ref No: n/a Documents to read alongside this Policy Study Leave Guidelines
More informationAGENDA ITEM NO: 046/17
AGENDA ITEM NO: 046/17 GOVERNING BODY MEETING: Governing Body Meeting DATE OF MEETING: 13 th September 2017 REPORT AUTHOR AND JOB TITLE: Rebecca Knight Head of Assurance & Risk REPORT TITLE: STRATEGIC
More information5.3: POLICY FOR THE MANAGEMENT OF REQUESTS FOR MEDICINES VIA PEER APPROVED CLINICAL SYSTEM (PACS) TIER 2
NHS GREATER GLASGOW AND CLYDE POLICIES RELATING TO THE MANAGEMENT OF MEDICINES SECTION 5: NON-FORMULARY PROCESSES 5.3: POLICY FOR THE MANAGEMENT OF REQUESTS FOR MEDICINES VIA PEER APPROVED CLINICAL SYSTEM
More informationBRIEFING REPORT ON VERBAL FEEDBACK FROM HEALTH & SAFETY MANAGEMENT AUDIT 2012/13
AGENDA ITEM 4.1 BRIEFING REPORT ON VERBAL FEEDBACK FROM HEALTH & SAFETY MANAGEMENT AUDIT 2012/13 Executive Lead: Deputy Chief Executive Author: Head of Health and Safety Contact Details for further information:
More informationNon-Medical Prescribing Strategy
Non-Medical Prescribing Strategy 2014-2017 Nursing & Partnerships Directorate Page 1 of 13 Section Contents Page No. 1. STATEMENT OF INTENT 3 2. PURPOSE 3 3. SCOPE 3 4. BACKGROUND 3 5. STRATEGIC GOALS
More informationThe Welsh NHS Confederation s response to the inquiry into cross-border health arrangements between England and Wales.
Welsh Affairs Committee. Purpose: The Welsh NHS Confederation s response to the inquiry into cross-border health arrangements between England and Wales. Contact: Nesta Lloyd Jones, Policy and Public Affairs
More informationLeeds West CCG Governing Body Meeting
Agenda Item: LW2015/115 FOI Exempt: N Leeds West CCG Governing Body Meeting Date of meeting: 4 vember 2015 Title: Delegated Commissioning of Primary Medical Services Lead Governing Body Member: Dr Simon
More informationSTANDARD OPERATING PROCEDURE FOR NON MEDICAL PRESCRIBERS. Standard operating procedure Page 1 of 15
STANDARD OPERATING PROCEDURE FOR NON MEDICAL PRESCRIBERS Page 1 of 15 Prepared August 2007 Review date August 2008 Reviewed August 2008 Expiry date August 2009 STANDARD OPERATING PROCEDURE NEW PROCESS
More informationBlood Transfusion Policy. Version Number: 6.1 Controlled Document Sponsor: Controlled Document Lead: On: December 2014.
Blood Transfusion Policy CONTROLLED DOCUMENT CATEGORY: CLASSIFICATION: PURPOSE Controlled Document Number: Policy Clinical The policy describes the framework and principles required to deliver best transfusion
More informationEXECUTIVE MEDICAL DIRECTOR JOB DESCRIPTION. Medical Education Leads Clinical Directors (professional leadership) Director of Clinical Audit
EXECUTIVE MEDICAL DIRECTOR JOB DESCRIPTION Job Title: Accountable to: Responsible for: Executive Medical Director Chief Executive Director of Research & Development Medical Education Leads Clinical Directors
More informationASBESTOS MANAGEMENT POLICY
ASBESTOS MANAGEMENT POLICY Version 5.0 File ref ASBESTOS MANAGEMENT POLICY Date approved June 2016 Date to be reviewed June 2019 To by reviewed by ASBESTOS STEERING GROUP Asbestos Management Policy June
More informationFocussed Independent Healthcare Inspection (Unannounced)
Focussed Independent Healthcare Inspection (Unannounced) St Joseph's Hospital, Newport Inspection date: 21 November 2017 Publication date: 22 February 2018 This publication and other HIW information can
More informationSUPPORTING DATA QUALITY NJR STRATEGY 2014/16
SUPPORTING DATA QUALITY NJR STRATEGY 2014/16 CONTENTS Supporting data quality 2 Introduction 2 Aim 3 Governance 3 Overview: NJR-healthcare provider responsibilities 3 Understanding current 4 data quality
More informationh. HULL AND EAST YORKSHIRE HOSPITALS NHS TRUST LEARNING FROM DEATHS POLICY. Broad Recommendations / Summary
201 2017.473h. HULL AND EAST YORKSHIRE HOSPITALS NHS TRUST LEARNING FROM DEATHS POLICY Broad Recommendations / Summary In-hospital death occurs. Patient 18 years of age or above. Yes Child Death Review
More informationBirmingham CrossCity Clinical Commissioning Group Deprivation of Liberty Safeguards (DoLS) Policy: Supervisory body Functions
Birmingham CrossCity Clinical Commissioning Group Deprivation of Liberty Safeguards (DoLS) Policy: Supervisory body Functions Policy Number Purpose of document To ensure that that the rights of patients
More informationService and job specific context statement
Service and job specific context statement Directorate: Service: Post title: Care and Support Team Manager Grade: Band 14 Responsible to: Staff managed: Service Manager Date of issue: April 2017 Job family:
More informationGovernance and Quality Committee Review. Wendy Pugh Director of Operations and Nursing. Innovation Tom Jinks - Governance Manager.
Board meeting date: 29 th May 2013 Agenda Item number:10.1 Enclosure:5 Title and Quality Committee Review Accountable Director: Author (name & title): Wendy Pugh Director of Operations and Nursing Rosie
More informationabcdefghijklmnopqrstu
Healthcare Policy and Strategy Directorate Quality Division Dear Colleague INTRODUCTION AND AVAILABILITY OF NEWLY LICENSED MEDICINES IN THE NHS IN SCOTLAND Dear Colleague This guidance sets out the policy
More informationNATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SPECIAL HEALTH AUTHORITY BUSINESS PLAN
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SPECIAL HEALTH AUTHORITY BUSINESS PLAN 2011/2012 to 2014/15 FINAL National Institute for Health and Clinical Excellence 1 Business Plan FINAL Contents
More informationAppendix 1: Public Health Business Plan: Priority One - Effective public health commissioning
Appendix 1: Public Health Business Plan: Priority One - Effective public health commissioning Activity 1. Develop Public Health strategic commissioning plan in line with the Public health Outcomes Framework
More informationDRAFT Welsh Assembly Government
DRAFT Welsh Assembly Government HEALTH, SOCIAL CARE AND WELL BEING STRATEGIES: POLICY GUIDANCE Status: Draft @ 031002 1 Welsh Assembly Government Health, Social Care and Well-being Strategies: Policy Guidance
More informationNOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST. Documentation Control. Central Alerting System (CAS) Dissemination Procedure
NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST Documentation Control Central Alerting System (CAS) Dissemination Procedure Reference HS/SP/001 Approving Body Senior Management Team Date Approved 14 March 2017
More informationWelsh Language Scheme Prepared under the Welsh Language Act 1993
Welsh Language Scheme Prepared under the Welsh Language Act 1993 Updated March 2007 W E L S H L A N G U A G E S C H E M E Introduction The Welsh Language Scheme of the Sports Council for Wales is prepared
More informationSection 2: Advanced level nursing practice competencies
Advanced Level Nursing Practice Section 2: Advanced level nursing practice competencies RCN Standards for advanced level nursing practice, advanced nurse practitioners, RCN accreditation and RCN credentialing
More informationMEMORANDUM OF UNDERSTANDING HEALTHCARE INSPECTORATE WALES THE PUBLIC SERVICES OMBUDSMAN FOR WALES
MEMORANDUM OF UNDERSTANDING BETWEEN HEALTHCARE INSPECTORATE WALES & THE PUBLIC SERVICES OMBUDSMAN FOR WALES Version Number: 1.0 Date agreed: 5 April 2016 1 Table of contents Table of contents... 2 1. Introduction...
More information